| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 140,617 | 144,770 | 133,536 | 198,851 | | Cost of Revenue | (195,793) | 94,756 | 101,037 | 116,987 | | | Gross Profit | 336,410 | 50,014 | 32,499 | 81,864 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 300,510 | 5,198 | 8,950 | 5,914 | | Non Recurring | 242,144 |
-
|
-
| 666,810 | | Others | 11,520 | 9,967 | 10,792 | 10,660 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (217,764) | 34,849 | 12,757 | (601,520) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (657) | (2,805) | 16,369 | 18,230 | | Earnings Before Interest And Taxes | (200,421) | 14,044 | 29,126 | (583,290) | | Interest Expense | 15,654 | 15,332 | 14,580 | 17,666 | | Income Before Tax | (216,075) | (1,288) | 14,546 | (600,956) | | Income Tax Expense | (83,554) | 6,417 | 5,635 | (116,850) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (150,521) | 10,295 | 8,911 | (484,106) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (497) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (150,521) | 10,295 | 8,911 | (484,603) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($150,521) | $10,295 | $8,911 | ($484,603) |
|
0.51% Nasdaq 
Income Statement
